$CERS
CERUS CORP

2021 Q1 Form 10-K Financial Statement

#000156459021008958 Filed on February 25, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2019 Q4 2019
Revenue $29.57M $26.49M $93.77M
YoY Change 20.01% 30.88% 23.3%
Cost Of Revenue $11.10M $9.290M $33.42M
YoY Change 33.35% 10.07% 5.64%
Gross Profit $18.47M $17.20M $60.36M
YoY Change 13.17% 45.76% 35.88%
Gross Profit Margin 62.46% 64.93% 64.36%
Selling, General & Admin $19.17M $17.16M $66.21M
YoY Change 20.47% 15.71% 16.47%
% of Gross Profit 103.79% 99.77% 109.69%
Research & Development $15.75M $16.44M $60.38M
YoY Change -0.39% 32.37% 41.85%
% of Gross Profit 85.26% 95.58% 100.03%
Depreciation & Amortization $794.0K $620.0K $2.403M
YoY Change 12.46% 82.35% 66.3%
% of Gross Profit 4.3% 3.6% 3.98%
Operating Expenses $34.92M $33.61M $126.6M
YoY Change 10.07% 23.29% 27.34%
Operating Profit -$16.45M -$16.41M -$66.23M
YoY Change 6.78% 6.14% 20.44%
Interest Expense $972.0K -$740.0K $6.065M
YoY Change -183.79% -35.65% 51.32%
% of Operating Profit
Other Income/Expense, Net -$912.0K $300.0K -$4.755M
YoY Change -708.0% -34.78% 102.6%
Pretax Income -$17.36M -$16.84M -$70.98M
YoY Change 5.79% 4.27% 23.8%
Income Tax $98.00K $80.00K $263.0K
% Of Pretax Income
Net Earnings -$17.46M -$16.92M -$71.24M
YoY Change 6.02% 4.43% 23.76%
Net Earnings / Revenue -59.04% -63.88% -75.97%
Basic Earnings Per Share -$0.12
Diluted Earnings Per Share -$103.4K -$0.12 -$509.3K
COMMON SHARES
Basic Shares Outstanding 168.2M 139.8M
Diluted Shares Outstanding 139.8M

Balance Sheet

Concept 2021 Q1 2019 Q4 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $131.7M $85.72M $83.30M
YoY Change -1.05% -27.1% -29.17%
Cash & Equivalents $59.81M $34.99M $32.60M
Short-Term Investments $74.10M $50.73M $50.70M
Other Short-Term Assets $7.000M $6.000M $8.400M
YoY Change 29.63% -14.29% 20.0%
Inventory $24.29M $19.49M $19.50M
Prepaid Expenses
Receivables $18.30M $16.88M $16.90M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $181.3M $128.1M $128.1M
YoY Change 1.68% -12.79% -12.8%
LONG-TERM ASSETS
Property, Plant & Equipment $26.10M $14.90M $29.00M
YoY Change -9.06% 83.25% 258.02%
Goodwill $1.316M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.90M $4.524M $7.000M
YoY Change 72.46% 11.7% 2.94%
Total Long-Term Assets $39.30M $37.43M $37.40M
YoY Change 5.93% 126.04% 125.3%
TOTAL ASSETS
Total Short-Term Assets $181.3M $128.1M $128.1M
Total Long-Term Assets $39.30M $37.43M $37.40M
Total Assets $220.6M $165.5M $165.5M
YoY Change 2.41% 1.27% 1.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.50M $22.19M $22.20M
YoY Change 11.39% 19.31% 19.35%
Accrued Expenses $19.75M $20.95M $22.60M
YoY Change 14.82% 5.81% 14.14%
Deferred Revenue $570.0K
YoY Change 14.46%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $9.900M $5.000M $5.000M
YoY Change 106.25% -36.71% -36.71%
Total Short-Term Liabilities $54.80M $50.34M $50.30M
YoY Change 21.51% -4.45% -4.55%
LONG-TERM LIABILITIES
Long-Term Debt $54.60M $39.40M $39.40M
YoY Change 38.23% 79.09% 79.09%
Other Long-Term Liabilities $18.60M $327.0K $18.70M
YoY Change 1.09% -92.31% 334.88%
Total Long-Term Liabilities $73.20M $327.0K $58.10M
YoY Change 26.42% -92.31% 120.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $54.80M $50.34M $50.30M
Total Long-Term Liabilities $73.20M $327.0K $58.10M
Total Liabilities $127.9M $108.5M $108.5M
YoY Change 24.17% 37.42% 37.52%
SHAREHOLDERS EQUITY
Retained Earnings -$850.1M
YoY Change 9.15%
Common Stock $907.0M
YoY Change 5.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $92.64M $57.05M $57.10M
YoY Change
Total Liabilities & Shareholders Equity $220.6M $165.5M $165.5M
YoY Change 2.41% 1.27% 1.22%

Cashflow Statement

Concept 2021 Q1 2019 Q4 2019
OPERATING ACTIVITIES
Net Income -$17.46M -$16.92M -$71.24M
YoY Change 6.02% 4.43% 23.76%
Depreciation, Depletion And Amortization $794.0K $620.0K $2.403M
YoY Change 12.46% 82.35% 66.3%
Cash From Operating Activities -$17.46M -$8.560M -$65.50M
YoY Change -11.85% 20.56% 109.62%
INVESTING ACTIVITIES
Capital Expenditures $193.0K -$480.0K $8.935M
YoY Change -57.3% -7.69% 681.03%
Acquisitions
YoY Change
Other Investing Activities $21.59M $9.880M $37.12M
YoY Change -143.41% 27.48% -186.93%
Cash From Investing Activities $21.39M $9.410M $28.19M
YoY Change -142.63% 30.15% -164.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $26.93M
YoY Change -68.33%
Debt Paid & Issued, Net $31.10M
YoY Change 23286.47%
Cash From Financing Activities 17.49M 9.490M 43.49M
YoY Change -74.54% 48.28% -53.11%
NET CHANGE
Cash From Operating Activities -17.46M -8.560M -65.50M
Cash From Investing Activities 21.39M 9.410M 28.19M
Cash From Financing Activities 17.49M 9.490M 43.49M
Net Change In Cash 20.90M 10.34M 5.834M
YoY Change -1704.3% 58.35% -66.96%
FREE CASH FLOW
Cash From Operating Activities -$17.46M -$8.560M -$65.50M
Capital Expenditures $193.0K -$480.0K $8.935M
Free Cash Flow -$17.65M -$8.080M -$74.43M
YoY Change -12.87% 22.8% 129.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020 us-gaap Revenue Practical Expedient Remaining Performance Obligation
RevenuePracticalExpedientRemainingPerformanceObligation
true
CY2020 cers Product Warranty Term
ProductWarrantyTerm
P1Y
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Entity File Number
EntityFileNumber
000-21937
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
68-0262011
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
1220 Concord Avenue
CY2020 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 600
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
Concord
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94520
CY2020 dei City Area Code
CityAreaCode
925
CY2020 dei Local Phone Number
LocalPhoneNumber
288-6000
CY2020 dei Security12b Title
Security12bTitle
Common Stock
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Small Business
EntitySmallBusiness
false
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2020Q2 dei Entity Public Float
EntityPublicFloat
928000000
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
168220090
CY2019Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
39414000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16873000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18406000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1174000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34986000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
50732000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16882000
CY2019Q4 us-gaap Inventory Net
InventoryNet
19490000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6018000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
128108000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14898000
CY2019Q4 us-gaap Goodwill
Goodwill
1316000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13122000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14122000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
132000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2435000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4524000
CY2019Q4 us-gaap Assets
Assets
165535000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
22185000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20951000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1613000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
570000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
50336000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
327000
CY2020Q4 us-gaap Liabilities
Liabilities
117609000
CY2019Q4 us-gaap Liabilities
Liabilities
108483000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
674000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
33419000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
31634000
CY2019 cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
41230000
CY2018 cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
29274000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
225000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
225000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
168170000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
168170000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
144291000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
144291000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
168000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
144000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1012932000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
906905000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
114000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-909968000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-850111000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
103806000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
57052000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
221415000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
165535000
CY2019 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
60376000
CY2018 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
42564000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
66205000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
56841000
CY2019 us-gaap Operating Expenses
OperatingExpenses
126581000
CY2018 us-gaap Operating Expenses
OperatingExpenses
99405000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-66226000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-54988000
CY2019 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-86000
CY2018 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-87000
CY2019 us-gaap Interest Expense
InterestExpense
6065000
CY2018 us-gaap Interest Expense
InterestExpense
4008000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1396000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1748000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-184000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-57748000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
38940000
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
85085000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18029000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
560000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4755000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2347000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-70981000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-57335000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
263000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
229000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-71244000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-57564000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.44
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
139831000
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
131663000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-71244000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-57564000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
395000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-57564000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
84519000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
26860000
CY2019 cers Issuance Of Common Stock From Exercise Of Stock Options Or Warrants And Vesting Of Restricted Stock Units And Employee Stock Purchase Plans Purchases Value
IssuanceOfCommonStockFromExerciseOfStockOptionsOrWarrantsAndVestingOfRestrictedStockUnitsAndEmployeeStockPurchasePlansPurchasesValue
3210000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13312000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
395000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-71244000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
57052000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
76272000
CY2020 cers Issuance Of Common Stock From Exercise Of Stock Options Or Warrants And Vesting Of Restricted Stock Units And Employee Stock Purchase Plans Purchases Value
IssuanceOfCommonStockFromExerciseOfStockOptionsOrWarrantsAndVestingOfRestrictedStockUnitsAndEmployeeStockPurchasePlansPurchasesValue
11750000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-59857000
CY2019 us-gaap Profit Loss
ProfitLoss
-71244000
CY2018 us-gaap Profit Loss
ProfitLoss
-57564000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2403000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1445000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
13312000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
10394000
CY2020 cers Non Cash Operating Lease Cost
NonCashOperatingLeaseCost
-1346000
CY2019 cers Non Cash Operating Lease Cost
NonCashOperatingLeaseCost
-1580000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-422000
CY2020 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
-234000
CY2018 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
-1248000
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-15000
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000
CY2020 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
274000
CY2020 cers Non Cash Interest Expense
NonCashInterestExpense
478000
CY2019 cers Non Cash Interest Expense
NonCashInterestExpense
386000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4284000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8130000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3663000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4030000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6043000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37421000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-49558000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
28185000
CY2020 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
11750000
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
85036000
CY2020 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
3499000
CY2019 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
5017000
CY2019 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
39433000
CY2019 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
31104000
CY2018 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
133000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
38000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40743000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-65838000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1615000
CY2018 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
80701000
CY2019 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
81027000
CY2018 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
37997000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
43487000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
92751000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5834000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17657000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-806000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
623000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1787000
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2744000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2236000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5017000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5683000
CY2020 cers Increase Decrease In Accrued Liabilities And Other Noncurrent Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherNoncurrentLiabilities
2760000
CY2019 cers Increase Decrease In Accrued Liabilities And Other Noncurrent Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherNoncurrentLiabilities
1295000
CY2018 cers Increase Decrease In Accrued Liabilities And Other Noncurrent Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherNoncurrentLiabilities
6046000
CY2019 cers Increase Decrease In Manufacturing And Development Payment Liability
IncreaseDecreaseInManufacturingAndDevelopmentPaymentLiability
-6288000
CY2018 cers Increase Decrease In Manufacturing And Development Payment Liability
IncreaseDecreaseInManufacturingAndDevelopmentPaymentLiability
-266000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
7000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
72000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31587000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
3077000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
2728000
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
229000
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
254000
CY2019 cers Non Cash Leasehold Improvements
NonCashLeaseholdImprovements
2949000
CY2018 cers Non Cash Leasehold Improvements
NonCashLeaseholdImprovements
2222000
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, management evaluates its estimates, including those related to the nature and timing of satisfaction of performance obligations, the timing when the customer obtains control of products or services, the standalone selling price (“SSP”) of performance obligations, variable consideration, <span style="Background-color:#FFFFFF;color:#000000;">the collectability of </span>accounts receivable, inventory reserves, fair values of investments, the allowance for credit losses, stock-based compensation, intangible assets and goodwill, useful lives of intangible assets and property and equipment, income taxes, accrued liabilities, and incremental borrowing rate, among others. The Company bases its estimates on historical experience, future projections, and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from those estimates under different assumptions or conditions.</p>
CY2020 us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
The Company invoices its customers based upon the terms in the contracts, which generally requires payment 30 to 60 days from the date of invoice.
CY2019Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
600000
CY2020 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, available-for-sale securities and accounts receivable.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the Company’s investment policy, substantially all of the Company’s cash, cash equivalents and available-for-sale securities are maintained at major financial institutions of high credit standing. The Company monitors the financial credit worthiness of the issuers of its investments and limits the concentration in individual securities and types of investments that exist within its investment portfolio. Generally, all of the Company’s investments carry high credit quality ratings, which is in accordance with its investment policy. At December 31, 2020, the Company does not believe there is significant financial risk from non-performance by the issuers of the Company’s cash equivalents and short-term investments.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of credit risk with respect to trade receivables exist. On a regular basis, including at the time of sale, the Company performs credit evaluations of its significant customers that it expects to sell to on credit terms. Generally, the Company does not require collateral from its customers to secure accounts receivable. To the extent that the Company determines specific invoices or customer accounts may be uncollectible, the Company establishes an allowance for doubtful accounts against the accounts receivable on its consolidated balance sheets and records a charge on its consolidated statements of operations as a component of selling, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">general</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and administrative expenses</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company had three customers that accounted for more than 10% of the Company’s outstanding trade receivables at both December 31, 2020 and December 31, 2019, respectively. These customers cumulatively represented approximately 51% and 56% of the Company’s outstanding trade receivables at December 31, 2020 and December 31, 2019, respectively. To date, the Company has not experienced collection difficulties from these customers.</p>
CY2019Q4 cers Cumulative Outstanding Trade Receivables Number Of Major Customers
CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers
3
CY2020 cers Work In Process Inventory Life Period
WorkInProcessInventoryLifePeriod
P1Y
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
500000
CY2020 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2019 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2018 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-71244000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-57564000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
139831000
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131663000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
139831000
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131663000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.44
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20834000
CY2020 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<p style="text-align:justify;margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Guarantee and Indemnification Arrangements</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes the fair value for guarantee and indemnification arrangements issued or modified by the Company. In addition, the Company monitors the conditions that are subject to the guarantees and indemnifications in order to identify if a loss has occurred. If the Company determines it is probable that a loss has occurred, then any such estimable loss would be recognized under those guarantees and indemnifications. Some of the agreements that the Company is a party to contain provisions that indemnify the counter party from damages and costs resulting from claims that the Company’s technology infringes the intellectual property rights of a third-party or claims that the sale or use of the Company’s products have caused personal injury or other damage or loss. The </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Company has not received any such requests for indemnification under these provisions and has not been required to make material payments pursuant to these provisions</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company generally provides for a <span style="-sec-ix-hidden:F_000458">one-year</span> warranty on certain of its INTERCEPT blood-safety products covering defects in materials and workmanship. The Company accrues costs associated with warranty obligations when claims become known and are estimable. The Company has not experienced significant or systemic warranty claims nor is it aware of any existing current warranty claims. Accordingly, the Company had not accrued for any future warranty costs for its products at December 31, 2020 and December 31, 2019.</p>
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
0
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
0
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3000
CY2020Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
103203000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
59478000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
114000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2019Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
59592000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
64857000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
65117000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
43822000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
43907000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
37672000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
38086000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
15656000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
15685000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
102529000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
103203000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
59478000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
59592000
CY2019Q4 us-gaap Inventory Net
InventoryNet
19490000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23446000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22528000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9579000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7630000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13867000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14898000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2200000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1100000
CY2020Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2019Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2018Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2019 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
103625000
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
59592000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5097000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5160000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
18157000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
14330000
CY2020Q4 us-gaap Inventory Net
InventoryNet
23254000
CY2019 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2020 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P10Y
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2000000.0
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1900000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5734000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4759000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24753000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20951000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
15999000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12703000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3020000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3489000
CY2020 cers Minimum Term Of Non Cancelable Operating Leases
MinimumTermOfNonCancelableOperatingLeases
P1Y
CY2020 cers Expiration Of Non Cancelable Operating Leases Maximum Year
ExpirationOfNonCancelableOperatingLeasesMaximumYear
2030
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
3400000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
344000
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y6M
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.090
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3535000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3008000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2840000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2735000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2716000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
13337000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
28171000
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
9383000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
18788000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
3300000
CY2018 us-gaap Operating Lease Cost
OperatingLeaseCost
3400000
CY2017 us-gaap Operating Lease Cost
OperatingLeaseCost
1600000
CY2020 us-gaap Lessor Operating Lease Lease Not Yet Commenced Description
LessorOperatingLeaseLeaseNotYetCommencedDescription
the Company had no leases that have not yet commenced.
CY2020Q4 cers Short Term Purchase Commitment Amount
ShortTermPurchaseCommitmentAmount
28900000
CY2020 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
4000000.0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
7900000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1600000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
7100000
CY2020Q4 cers Accrual For Manufacturing Of Entity Products
AccrualForManufacturingOfEntityProducts
13838000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.71
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.73
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.41
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18029000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13312000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10394000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.60
CY2020 cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
31300000
CY2019 cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
29500000
CY2018 cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
21300000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
638103000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
75407000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
610000
CY2019Q4 cers Accrual For Manufacturing Of Entity Products
AccrualForManufacturingOfEntityProducts
8470000
CY2020Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
2380000
CY2019Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
1796000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-61246000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-71946000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-58048000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1673000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
965000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
713000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59573000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-70981000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-57335000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
274000
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
255000
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
225000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
274000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
257000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
225000
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
6000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
4000
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
3000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
4000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
2000
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1000
CY2020 cers Deferred Income Tax Expense Benefit And Tax Benefit From Unrealized Gain On Available For Sale Securities Operating Activities
DeferredIncomeTaxExpenseBenefitAndTaxBenefitFromUnrealizedGainOnAvailableForSaleSecuritiesOperatingActivities
10000
CY2019 cers Deferred Income Tax Expense Benefit And Tax Benefit From Unrealized Gain On Available For Sale Securities Operating Activities
DeferredIncomeTaxExpenseBenefitAndTaxBenefitFromUnrealizedGainOnAvailableForSaleSecuritiesOperatingActivities
6000
CY2018 cers Deferred Income Tax Expense Benefit And Tax Benefit From Unrealized Gain On Available For Sale Securities Operating Activities
DeferredIncomeTaxExpenseBenefitAndTaxBenefitFromUnrealizedGainOnAvailableForSaleSecuritiesOperatingActivities
4000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
284000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
263000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
229000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-12510000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-14906000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-12040000
CY2019Q4 cers Deferred Tax Assets Capitalized Research And Development Costs
DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
12832000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
10957000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
9843000
CY2020Q4 cers Deferred Tax Assets Operating Leases
DeferredTaxAssetsOperatingLeases
4214000
CY2019Q4 cers Deferred Tax Assets Operating Leases
DeferredTaxAssetsOperatingLeases
4374000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
6051000
CY2020 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1630000
CY2019 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1857000
CY2018 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1390000
CY2020 cers Income Tax Reconciliation State Tax Credits Research
IncomeTaxReconciliationStateTaxCreditsResearch
749000
CY2019 cers Income Tax Reconciliation State Tax Credits Research
IncomeTaxReconciliationStateTaxCreditsResearch
821000
CY2018 cers Income Tax Reconciliation State Tax Credits Research
IncomeTaxReconciliationStateTaxCreditsResearch
655000
CY2020 cers Income Tax Reconciliation Expiration Of Federal Net Operating Losses
IncomeTaxReconciliationExpirationOfFederalNetOperatingLosses
9200000
CY2019 cers Income Tax Reconciliation Expiration Of Federal Net Operating Losses
IncomeTaxReconciliationExpirationOfFederalNetOperatingLosses
5472000
CY2018 cers Income Tax Reconciliation Expiration Of Federal Net Operating Losses
IncomeTaxReconciliationExpirationOfFederalNetOperatingLosses
4154000
CY2018 cers Income Tax Reconciliation Expiration Of State And Local Net Operating Losses
IncomeTaxReconciliationExpirationOfStateAndLocalNetOperatingLosses
-1344000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6738000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
13059000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
9913000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
978000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
158000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-361000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1921000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1111000
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1141000
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
178000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
269000
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
405000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
284000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
263000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
229000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
141176000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
135536000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
28892000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
28291000
CY2020Q4 cers Deferred Tax Assets Capitalized Research And Development Costs
DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
10756000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
4547000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
202046000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
195423000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
199042000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
192304000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3004000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3119000
CY2020Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
2892000
CY2019Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
3017000
CY2020Q4 cers Deferred Tax Liabilities Amortization Of Intangible Assets
DeferredTaxLiabilitiesAmortizationOfIntangibleAssets
163000
CY2019Q4 cers Deferred Tax Liabilities Amortization Of Intangible Assets
DeferredTaxLiabilitiesAmortizationOfIntangibleAssets
143000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3055000
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3160000
CY2020 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
6700000
CY2019 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
13100000
CY2018 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
-9900000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10842000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
11063000
CY2020 cers Unrecognized Tax Benefits Decreases Resulting From Expired Carryforwards
UnrecognizedTaxBenefitsDecreasesResultingFromExpiredCarryforwards
1171000
CY2019 cers Unrecognized Tax Benefits Decreases Resulting From Expired Carryforwards
UnrecognizedTaxBenefitsDecreasesResultingFromExpiredCarryforwards
729000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
439000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
508000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10110000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10842000
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
114249000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
93774000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76051000
CY2020Q4 us-gaap Noncurrent Assets
NoncurrentAssets
13867000
CY2019Q4 us-gaap Noncurrent Assets
NoncurrentAssets
15030000

Files In Submission

Name View Source Status
0001564590-21-008958-index-headers.html Edgar Link pending
0001564590-21-008958-index.html Edgar Link pending
0001564590-21-008958.txt Edgar Link pending
0001564590-21-008958-xbrl.zip Edgar Link pending
cers-10k_20201231.htm Edgar Link pending
cers-10k_20201231_htm.xml Edgar Link completed
cers-20201231.xsd Edgar Link pending
cers-20201231_cal.xml Edgar Link unprocessable
cers-20201231_def.xml Edgar Link unprocessable
cers-20201231_lab.xml Edgar Link unprocessable
cers-20201231_pre.xml Edgar Link unprocessable
cers-ex1014_181.htm Edgar Link pending
cers-ex1016_182.htm Edgar Link pending
cers-ex102_179.htm Edgar Link pending
cers-ex108_180.htm Edgar Link pending
cers-ex211_11.htm Edgar Link pending
cers-ex231_12.htm Edgar Link pending
cers-ex311_15.htm Edgar Link pending
cers-ex312_14.htm Edgar Link pending
cers-ex321_13.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gyjvqnxhp1i2000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending